Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information


EU orphan designation number: EU/3/03/141
Active ingredient: 2-chloro-9-[2-deoxy-2-fluoro-ß-D-arabinofuranosyl]adenine.
Indication: Treatment of acute myeloid leukaemia
Sponsor: Genzyme Europe B.V.
Gooimeer 10, 1411 DD Naarden, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/05/2003 Orphan designation EMEA/OD/065/02 (2003)1577 of 08/05/2003
05/02/2007 Change of name and/or address of sponsor
27/05/2008 Transfer of orphan designation EMEA/OD/065/02/T/01 (2008)2288 of 23/05/2008
08/07/2014 Removal of orphan designation from Community Register